{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T13:35:28Z","timestamp":1771076128322,"version":"3.50.1"},"reference-count":137,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T00:00:00Z","timestamp":1183507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2003<\/jats:bold> Kidney disease, especially chronic kidney disease (CKD), is a worldwide public health problem with serious adverse health consequences for affected individuals. Secondary hyperparathyroidism, a disorder characterized by elevated serum parathyroid hormone levels, and alteration of calcium and phosphorus homeostasis are common metabolic complications of CKD that may impact cardiovascular health.<\/jats:p><jats:p><jats:bold>Materials and methods\u2003<\/jats:bold> Here, we systematically review published reports from recent observational studies and clinical trials that examine markers of altered mineral metabolism and clinical outcomes in patients with CKD.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> Mineral metabolism disturbances begin early during the course of chronic kidney disease, and are associated with cardiovascular disease and mortality in observational studies. Vascular calcification is one plausible mechanism connecting renal\u2010related mineral metabolism with cardiovascular risk. Individual therapies to correct mineral metabolism disturbances have been associated with clinical benefit in some observational studies; clinical trials directed at more comprehensive control of this problem are warranted.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> There exists a potential to improve outcomes for patients with CKD through increased awareness of the Bone Metabolism and Disease guidelines set forth by the National Kidney Foundation\u2013Kidney Disease Outcomes Quality Initiative. Future studies may include more aggressive therapy with a combination of agents that address vitamin D deficiency, parathyroid hormone and phosphorus excess, as well as novel agents that modulate circulating promoters and inhibitors of calcification.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2007.01840.x","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T15:01:58Z","timestamp":1183561318000},"page":"607-622","source":"Crossref","is-referenced-by-count":46,"title":["Mineral metabolism disturbances in patients with chronic kidney disease"],"prefix":"10.1111","volume":"37","author":[{"given":"B.","family":"Kestenbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Belozeroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,4]]},"reference":[{"key":"e_1_2_9_2_2","first-page":"1","article-title":"Deaths: final data for 2003","volume":"54","author":"Hoyert DL","year":"2006","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004070539"},{"key":"e_1_2_9_4_2","unstructured":"FoundationNK.Chronic kidney disease (CKD).http:\/\/www.kidney.org\/kidneydisease\/ckd\/index.cfm 2006."},{"key":"e_1_2_9_5_2","volume-title":"USRDS 2006 Annual Data Report: Atlas of End\u2010Stage Renal Disease in the United States","author":"United States Renal Data System","year":"2006"},{"key":"e_1_2_9_6_2","first-page":"869","article-title":"Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors","volume":"70","author":"Johnson CA","year":"2004","journal-title":"Am Fam Physician"},{"key":"e_1_2_9_7_2","unstructured":"National Kidney Foundation.End Stage Renal Disease in the United States.http:\/\/www.kidney.org\/news\/newsroom\/fsitem.cfm?id=38.2006."},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000102971.85504.7c"},{"key":"e_1_2_9_9_2","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program.Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report2002.","DOI":"10.1001\/jama.285.19.2486"},{"issue":"7","key":"e_1_2_9_10_2","first-page":"vii2","article-title":"Epidemiology of cardiovascular risk in patients with chronic kidney disease","volume":"18","author":"Locatelli F","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.060002472.x"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.12.1548"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.7.1014"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000414"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-005-0666-8"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.2174\/1566524054553531"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-005-0665-9"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612023393387"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80977-2"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1991.71.2.371"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000073945"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh125"},{"key":"e_1_2_9_23_2","first-page":"325","article-title":"Detection and quantification of cardiovascular calcifications with electron beam tomography to estimate risk in hemodialysis patients","volume":"54","author":"Raggi P.","year":"2000","journal-title":"Clin Nephrol"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000133041.27682.A2"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(04)01103-5"},{"key":"e_1_2_9_26_2","doi-asserted-by":"crossref","unstructured":"SlininY FoleyRN CollinsAJ.Calcium phosphorus parathyroid hormone and cardiovascular disease in hemodialysis patients. the USRDS waves 1 2005 3 and 4 study.J Am Soc Nephrol16: 1788\u201393.","DOI":"10.1681\/ASN.2004040275"},{"key":"e_1_2_9_27_2","unstructured":"National Kidney Foundation.K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.2003."},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33398"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.20754"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v31.pm9531176"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.29254"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00185.x"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001542"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.08.013"},{"key":"e_1_2_9_35_2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089686080202200207","article-title":"Normal or low initial PTH levels are not a predictor of morbidity\/mortality in patients undergoing chronic peritoneal dialysis","volume":"22","author":"Dimkovic NB","year":"2002","journal-title":"Perit Dial Int"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001606"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.05.025"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004070602"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005101085"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.09.022"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005010052"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5084"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.12.062"},{"key":"e_1_2_9_44_2","first-page":"1425","article-title":"Cardiovascular risk factors in dialyzed patients","volume":"112","author":"Kobus G","year":"2004","journal-title":"Pol Arch Med Wewn"},{"key":"e_1_2_9_45_2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/039139880302600303","article-title":"Relationship between diabetes mellitus and degree of coronary artery disease in uraemic patients investigated with coronary angiography","volume":"26","author":"Fabbian F","year":"2003","journal-title":"Int J Artif Organs"},{"key":"e_1_2_9_46_2","doi-asserted-by":"crossref","unstructured":"QunibiWY.Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end\u2010stage renal disease (ESRD).KidneyInt Suppl2005;(95):S43\u201350.","DOI":"10.1111\/j.1523-1755.2005.09507.x"},{"key":"e_1_2_9_47_2","first-page":"405","article-title":"Plasma homocysteine levels and cardiovascular mortality in patients with end\u2010stage renal disease","volume":"17","author":"Buccianti G","year":"2004","journal-title":"J Nephrol"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00018.x"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.4.454"},{"issue":"1","key":"e_1_2_9_50_2","first-page":"68","article-title":"Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy","volume":"22","author":"Cases A","year":"2002","journal-title":"Nefrologia"},{"key":"e_1_2_9_51_2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca\u00a0\u00d7\u00a0PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh SK","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_9_52_2","doi-asserted-by":"crossref","unstructured":"MarcoMP CraverL BetriuA BelartM FiblaJ FernandezE.Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population.Kidney Int Suppl2003;??:S111\u20134.","DOI":"10.1046\/j.1523-1755.63.s85.26.x"},{"key":"e_1_2_9_53_2","first-page":"67","article-title":"Close association between parathyroid hormone and left ventricular function and structure in end\u2010stage renal failure patients under maintenance hemodialysis","volume":"31","author":"Nasri H","year":"2004","journal-title":"Acta Med Austriaca"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2005000900016"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1159\/000078700"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50050"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00375.x"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00803.x"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.11.025"},{"key":"e_1_2_9_60_2","first-page":"143","article-title":"Cardiovascular calcifications in hemodialysis patients. Prevalence and risk factors","volume":"24","author":"Benamar L","year":"2003","journal-title":"Nephrologie"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043798-200106000-00003"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1156-7"},{"key":"e_1_2_9_63_2","first-page":"50","article-title":"Calcification of peripheral arteries in patients with terminal renal failure on programmed hemodialysis","volume":"77","author":"Dzitoeva M","year":"2005","journal-title":"Ter Arkh"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.3.327"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1259\/dmfr\/72474954"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2003.08.010"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1161\/hy1001.096358"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000020222.63035.C0"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00402.x"},{"key":"e_1_2_9_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00973.x"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004100884"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000070071.57901.B3"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00675-9"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-006-0126-z"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg414"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP62104"},{"key":"e_1_2_9_77_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00434.x"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004100895"},{"key":"e_1_2_9_79_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mat.0000202606.44826.6b"},{"key":"e_1_2_9_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12710-9"},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00600.x"},{"key":"e_1_2_9_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90865-Z"},{"key":"e_1_2_9_83_2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.V103594","article-title":"Asymmetric dimethylarginine plasma concentrations differ in patients with end\u2010stage renal disease: relationship to treatment method and atherosclerotic disease","volume":"10","author":"Kielstein JT","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_9_84_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi308"},{"key":"e_1_2_9_85_2","first-page":"303","article-title":"Correlation of back pain, compression fracture and quadriceps muscle strength with bone mineral density in renal insufficiency patients","volume":"41","author":"Terzibasioglu AM","year":"2005","journal-title":"Eura Medicophys"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00178.x"},{"key":"e_1_2_9_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2000.00394.x"},{"key":"e_1_2_9_88_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006050546"},{"key":"e_1_2_9_89_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.19812"},{"key":"e_1_2_9_90_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.09.024"},{"key":"e_1_2_9_91_2","doi-asserted-by":"publisher","DOI":"10.1159\/000065222"},{"key":"e_1_2_9_92_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.32006"},{"key":"e_1_2_9_93_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00837.x"},{"key":"e_1_2_9_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90363-7"},{"key":"e_1_2_9_95_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000129337.50739.48"},{"key":"e_1_2_9_96_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403313301301"},{"key":"e_1_2_9_97_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00972.x"},{"key":"e_1_2_9_98_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6976.358"},{"key":"e_1_2_9_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg595"},{"key":"e_1_2_9_100_2","first-page":"303","article-title":"Pulse oral versus pulse intraperitoneal calcitriol: a comparison of efficacy in the treatment of hyperparathyroidism and renal osteodystrophy in peritoneal dialysis patients","volume":"16","author":"Gadallah MF","year":"2000","journal-title":"Adv Perit Dial"},{"key":"e_1_2_9_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.6.877"},{"key":"e_1_2_9_102_2","doi-asserted-by":"publisher","DOI":"10.1159\/000049041"},{"key":"e_1_2_9_103_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188515"},{"key":"e_1_2_9_104_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650100205"},{"key":"e_1_2_9_105_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.01.012"},{"key":"e_1_2_9_106_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00775.x"},{"key":"e_1_2_9_107_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.12.2228"},{"key":"e_1_2_9_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83128-2"},{"key":"e_1_2_9_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00755.x"},{"key":"e_1_2_9_110_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00316.2003"},{"key":"e_1_2_9_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1993.tb08210.x"},{"key":"e_1_2_9_112_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.12.2132"},{"key":"e_1_2_9_113_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.6.2967"},{"key":"e_1_2_9_114_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.2.888"},{"key":"e_1_2_9_115_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004070573"},{"key":"e_1_2_9_116_2","first-page":"428","article-title":"The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end\u2010stage renal disease","volume":"64","author":"Freemont AJ","year":"2005","journal-title":"Clin Nephrol"},{"key":"e_1_2_9_117_2","doi-asserted-by":"crossref","unstructured":"D\u2019HaesePC SpasovskiGB SikoleA HutchisonA FreemontTJ SulkovaSet\u00a0al.A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.Kidney Int Suppl2003;(85):S73\u20138.","DOI":"10.1046\/j.1523-1755.63.s85.18.x"},{"key":"e_1_2_9_118_2","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-65259"},{"key":"e_1_2_9_119_2","doi-asserted-by":"crossref","unstructured":"HervasJG PradosD CerezoS.Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate.Kidney Int Suppl2003;(85):S69\u201372.","DOI":"10.1046\/j.1523-1755.63.s85.17.x"},{"key":"e_1_2_9_120_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.3.582"},{"key":"e_1_2_9_121_2","first-page":"134","article-title":"Valvular calcification in hemodialysis patients randomized to calcium\u2010based phosphorus binders or sevelamer","volume":"13","author":"Raggi P","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"e_1_2_9_122_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002059"},{"key":"e_1_2_9_123_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041221"},{"key":"e_1_2_9_124_2","doi-asserted-by":"publisher","DOI":"10.1159\/000065273"},{"key":"e_1_2_9_125_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.057273"},{"key":"e_1_2_9_126_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031633"},{"key":"e_1_2_9_127_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004060512"},{"key":"e_1_2_9_128_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00596.x"},{"key":"e_1_2_9_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(01)01060-2"},{"key":"e_1_2_9_130_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004020138"},{"key":"e_1_2_9_131_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.04.006"},{"key":"e_1_2_9_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(93)90238-6"},{"key":"e_1_2_9_133_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.09.013"},{"key":"e_1_2_9_134_2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ndt\/9.5.524","article-title":"Acute effect of oral, intraperitoneal, and intravenous 1\u03b1\u2010hydroxycholecalciferol on markers of bone metabolism","volume":"9","author":"Joffe P","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_9_135_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01809.x"},{"key":"e_1_2_9_136_2","first-page":"111","article-title":"Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients","volume":"45","author":"Janssen MJ","year":"1996","journal-title":"Clin Nephrol"},{"key":"e_1_2_9_137_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20781"},{"key":"e_1_2_9_138_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021736"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2007.01840.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2007.01840.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T13:51:19Z","timestamp":1697205079000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2007.01840.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,4]]},"references-count":137,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1365-2362.2007.01840.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2007.01840.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,4]]}}}